tradingkey.logo

Indivior PLC

INDV
36.090USD
-0.070-0.19%
交易中 美東報價延遲15分鐘
4.51B總市值
36.69本益比TTM

Indivior PLC

36.090
-0.070-0.19%

關於 Indivior PLC 公司

Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.

Indivior PLC簡介

公司代碼INDV
公司名稱Indivior PLC
上市日期Dec 24, 2014
CEOCiaffoni (Joseph J)
員工數量1030
證券類型Ordinary Share
年結日Dec 24
公司地址234 Bath Road
城市SLOUGH
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United Kingdom
郵編SL1 4EE
電話448043791090
網址https://www.indivior.com/en
公司代碼INDV
上市日期Dec 24, 2014
CEOCiaffoni (Joseph J)

Indivior PLC公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--
Ms. Juliet Thompson
Ms. Juliet Thompson
Senior Non-Executive Independent Director
Senior Non-Executive Independent Director
9.63K
+150.00%
Dr. Keith Humphreys
Dr. Keith Humphreys
Non-Executive Independent Director
Non-Executive Independent Director
3.88K
+63.05%
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Chief Legal Officer
760.00
--
Mr. Stuart (Tony) Kingsley
Mr. Stuart (Tony) Kingsley
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Vishal Kalia
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
137.46K
+3.25%
Mr. Christian Heidbreder
Mr. Christian Heidbreder
Chief Scientific Officer
Chief Scientific Officer
132.64K
+42.74%
Ms. Cynthia (Cindy) Cetani
Ms. Cynthia (Cindy) Cetani
Chief Integrity and Compliance Officer
Chief Integrity and Compliance Officer
121.74K
--
Mr. Hillel West
Mr. Hillel West
Chief Manufacturing and Supply Officer
Chief Manufacturing and Supply Officer
121.72K
+338.91%
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
56.00K
--
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Mr. Daniel A. (Dan) Ninivaggi, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
15.00K
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
256.00M
84.77%
Rest of World
46.00M
15.23%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月4日 週四
更新時間: 12月4日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Oaktree Capital Management, L.P.
7.00%
BlackRock Institutional Trust Company, N.A.
6.24%
Madison Avenue Partners LP
5.18%
Goldman Sachs & Company, Inc.
5.13%
Two Seas Capital LP
4.98%
其他
71.47%
持股股東
持股股東
佔比
Oaktree Capital Management, L.P.
7.00%
BlackRock Institutional Trust Company, N.A.
6.24%
Madison Avenue Partners LP
5.18%
Goldman Sachs & Company, Inc.
5.13%
Two Seas Capital LP
4.98%
其他
71.47%
股東類型
持股股東
佔比
Hedge Fund
33.71%
Investment Advisor/Hedge Fund
28.33%
Investment Advisor
17.97%
Research Firm
12.00%
Individual Investor
3.87%
Pension Fund
0.61%
Bank and Trust
0.32%
Family Office
0.27%
Insurance Company
0.04%
其他
2.88%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
372
118.02M
94.53%
+2.51M
2025Q2
354
123.13M
98.21%
+4.02M
2025Q1
380
119.99M
96.15%
-1.70M
2024Q4
382
116.83M
93.64%
-10.43M
2024Q3
369
117.73M
91.72%
-15.91M
2024Q2
352
119.29M
90.10%
-8.99M
2024Q1
341
129.79M
96.57%
+3.79M
2023Q4
322
124.43M
92.28%
+2.93M
2023Q3
321
114.40M
84.40%
+17.06M
2023Q2
296
115.50M
83.90%
+12.51M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Oaktree Capital Management, L.P.
11.01M
8.82%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.04M
4.04%
+5.03M
+68055.48%
Jun 30, 2025
Madison Avenue Partners LP
7.92M
6.35%
+130.09K
+1.67%
Jun 30, 2025
Two Seas Capital LP
10.33M
8.28%
-1.33M
-11.43%
Sep 03, 2025
Deerfield Management Company, L.P.
10.57M
8.47%
--
--
Jun 30, 2025
Newtyn Management, LLC
2.61M
2.09%
+956.08K
+57.91%
Jun 30, 2025
The Vanguard Group, Inc.
5.63M
4.51%
+1.02M
+22.15%
Jun 30, 2025
Sirovich (Matthew I.)
3.42M
2.74%
+249.62K
+7.87%
Sep 30, 2024
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Lattice Hartford Multifactor Small Cap ETF
1.11%
ProShares Ultra Nasdaq Biotechnology
0.51%
Federated Hermes MDT Small Cap Core ETF
0.47%
Janus Henderson Small Cap Growth Alpha ETF
0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
0.38%
Invesco Nasdaq Biotechnology ETF
0.36%
Franklin US Small Cap Multifactor Index ETF
0.32%
First Trust Active Factor Small Cap ETF
0.31%
Vanguard US Multifactor ETF
0.27%
Pacer US Small Cap Cash Cows ETF
0.26%
查看更多
Lattice Hartford Multifactor Small Cap ETF
佔比1.11%
ProShares Ultra Nasdaq Biotechnology
佔比0.51%
Federated Hermes MDT Small Cap Core ETF
佔比0.47%
Janus Henderson Small Cap Growth Alpha ETF
佔比0.43%
First Trust Multi-Manager Small Cap Opportunities ETF
佔比0.38%
Invesco Nasdaq Biotechnology ETF
佔比0.36%
Franklin US Small Cap Multifactor Index ETF
佔比0.32%
First Trust Active Factor Small Cap ETF
佔比0.31%
Vanguard US Multifactor ETF
佔比0.27%
Pacer US Small Cap Cash Cows ETF
佔比0.26%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Indivior PLC的前五大股東是誰?

Indivior PLC的前五大股東如下:
Oaktree Capital Management, L.P.
持有股份:11.01M
佔總股份比例:8.82%。
BlackRock Institutional Trust Company, N.A.
持有股份:5.04M
佔總股份比例:4.04%。
Madison Avenue Partners LP
持有股份:7.92M
佔總股份比例:6.35%。
Two Seas Capital LP
持有股份:10.33M
佔總股份比例:8.28%。
Deerfield Management Company, L.P.
持有股份:10.57M
佔總股份比例:8.47%。

Indivior PLC的前三大股東類型是什麼?

Indivior PLC 的前三大股東類型分別是:
Oaktree Capital Management, L.P.
BlackRock Institutional Trust Company, N.A.
Madison Avenue Partners LP

有多少機構持有Indivior PLC(INDV)的股份?

截至2025Q3,共有372家機構持有Indivior PLC的股份,合計持有的股份價值約為118.02M,占公司總股份的94.53% 。與2025Q2相比,機構持股有所增加,增幅為-3.68%。

哪個業務部門對Indivior PLC的收入貢獻最大?

在FY2025Q2,--業務部門對Indivior PLC的收入貢獻最大,創收--,占總收入的--% 。
KeyAI